4.6 Article

A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 51, Pages 36451-36462

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M113.505727

Keywords

Autophagy; Protein Degradation; Protein Stability; Rho GTPases; T Cell; Atypical Rho GTPases; B-Cell Malignancies; RhoH; Carboxyl Terminus; Chaperone-mediated Autophagy

Funding

  1. National Institutes of Health [CA113969]
  2. Deutsche Forschungsgemeinschaft [TR 1005/1-1]

Ask authors/readers for more resources

Background: RhoH is required for T cell development and non-coding RhoH mutations are found in B-cell lymphoma. Results: The C-terminal insert domain regulates RhoH protein stability via chaperone-mediated autophagy. Conclusion: Although the insert domain is required for lysosomal uptake, it is dispensable for T cell development. Significance: Targeting the insert domain may permit alteration of RhoH protein levels without impairing vital protein functions. RhoH is a hematopoietic-specific, GTPase-deficient member of the Rho GTPase family that was first identified as a hypermutable gene in human B lineage lymphomas. RhoH remains in a constitutively active state and thus its effects are regulated by expression levels or post-translational modifications. Similar to other small GTPases, intracellular localization of RhoH is dependent upon the conserved CAAX box and surrounding sequences within the carboxyl (C) terminus. However, RhoH also contains a unique C-terminal insert domain of yet undetermined function. RhoH serves as adaptor molecule in T cell receptor signaling and RhoH expression correlates with the unfavorable prognostic marker ZAP70 in human chronic lymphocytic leukemia. Disease progression is attenuated in a Rhoh(-/-) mouse model of chronic lymphocytic leukemia and treatment of primary human chronic lymphocytic leukemia cells with Lenalidomide results in reduced RhoH protein levels. Thus, RhoH is a potential therapeutic target in B cell malignancies. In the current studies, we demonstrate that deletion of the insert domain (LFSINE) results in significant cytoplasmic protein accumulation. Using inhibitors of degradation pathways, we show that LFSINE regulates lysosomal RhoH uptake and degradation via chaperone-mediated autophagy. Whereas the C-terminal prenylation site is critical for ZAP70 interaction, subcellular localization and rescue of the Rhoh(-/-) T cell defect in vivo, the insert domain appears dispensable for these functions. Taken together, our findings suggest that the insert domain regulates protein stability and activity without otherwise affecting RhoH function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available